Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.
22nd Century To Secure $5.3M Via Registered Direct Offering Priced Above Market
22nd Century Group, Inc. (NASDAQ: XXII) has entered into definitive agreements with certain investors for the purchase and sale of 11.2 million shares of common stock and warrants at a price of $0.47 per share in a registered direct offering priced above market.
